Mitral regurgitation is the most common form of valvular heart disease and affects around 10% of Americans over 75. It occurs when the mitral ...

The most common etiologies of mitral regurgitation (MR) include degenerative and functional pathologies. MitraClip® (Abbott Vascular, CA, USA), a new device for transcatheter mitral valve repair ...

Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic ...

The Cardiac Dimensions Carillon Mitral Contour System is a minimally invasive mitral regurgitation therapy made possible by ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

Cosgrove brings a unique perspective to the field of mitral valve repair with the development of the Cosgrove-Edwards annuloplasty system. It is for use in the mitral or tricuspid position.

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...

Mitral valve annuloplasty devices are expected to see ... However, the analyst said the increasing adoption of transcatheter mitral valve repair and transcatheter aortic valve replacement devices ...

allowing it to begin an early feasibility study of its transcatheter device, the Amend Trans-Septal System, designed for the treatment of mitral insufficiency. Amend features a closed, semi-rigid ...